{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T00:08:02Z","timestamp":1703722082788},"reference-count":0,"publisher":"Salvia Medical Sciences Ltd","license":[{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["GMJ"],"abstract":"<jats:p>Background: The global prevalence of hypertensive pregnancy disorders (HPDs) is 5.2%-8.2%. Lipid profiles made up of triglycerides (TG), total cholesterol (TC), low-density lipoprotein-cholesterol (LDL), and high-density lipoprotein-cholesterol (HDL) could affect the arterial vessel wall leading to HPDs. Preeclampsia (PE), among the most severe maternal-fetal HPDs, has affected 0.2%-9.2% of all pregnancies. The current study aimed to investigate the role of lipid profiles in predicting PE in the first and early third trimesters of pregnancy. Material and Method: A large-scale prospective cohort study was conducted from early pregnancy onward in a normal population in the south of Iran. Fasting blood samples were examined for TG, TC, HDL, and LDL, as well as LDL\/HDL ratio levels in the first and early third trimesters. Result: Of 486 pregnant women, 37 women developed HPDs, of which 20 (54%) developed PE. In the PE group, the levels of serum lipid profiles, including TG, TC, LDL, and HDL, significantly raised with gestational age (P&lt;0.05). After adjusting for maternal age and body mass index, TG, TC, LDL, and LDL\/HDL ratio levels were associated with a higher risk of PE (odds ratio [OR]=1.025, 1.035, 1.03, 2.08, and 1.026, 1.044, 1.03, 2.14, P&lt;0.001) regarding the first and early third trimesters, respectively. The optimum cut-off points for TG, TC, LDL, and LDL\/HDL ratios predicting PE were estimated to be 180.5 mg\/dl, 197.5 mg\/dl, 136 mg\/dl, and 3.66 in the first, and 220 mg\/dl, 204 mg\/dl, 155.5 mg\/dl, and 3.97 in the early third trimesters. Conclusion: Dyslipidemia during pregnancy may help predict PE development that can be sustained with lipid-lowering drugs. [GMJ.2022;11:e2395]<\/jats:p>","DOI":"10.31661\/gmj.v11i.2395","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T17:50:19Z","timestamp":1675101019000},"source":"Crossref","is-referenced-by-count":0,"title":["Hypertensive Pregnancy Disorders and Lipid Profiles: A Cohort Study"],"prefix":"10.31661","volume":"11","author":[{"given":"Marjan","family":"Zare","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azam","family":"Faraji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behnaz","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16705","published-online":{"date-parts":[[2022,12,30]]},"container-title":["Galen Medical Journal"],"original-title":[],"link":[{"URL":"https:\/\/journals.salviapub.com\/index.php\/gmj\/article\/download\/2395\/2652","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.salviapub.com\/index.php\/gmj\/article\/download\/2395\/2654","content-type":"application\/epub+zip","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.salviapub.com\/index.php\/gmj\/article\/download\/2395\/2653","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.salviapub.com\/index.php\/gmj\/article\/download\/2395\/2652","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T09:52:24Z","timestamp":1703670744000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.salviapub.com\/index.php\/gmj\/article\/view\/2395"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31661\/gmj.v11i.2395","relation":{},"ISSN":["2322-2379","2588-2767"],"issn-type":[{"value":"2322-2379","type":"electronic"},{"value":"2588-2767","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,30]]}}}